Pfizer Inc. (PFE)
Pfizer Statistics
Share Statistics
Pfizer has 5.67B shares outstanding. The number of shares has increased by 0.36% in one year.
| Shares Outstanding | 5.67B |
| Shares Change (YoY) | 0.36% |
| Shares Change (QoQ) | 0.01% |
| Owned by Institutions (%) | 65.8% |
| Shares Floating | 5.66B |
| Failed to Deliver (FTD) Shares | 65.39K |
| FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 91.78M, so 1.62% of the outstanding shares have been sold short.
| Short Interest | 91.78M |
| Short % of Shares Out | 1.62% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 2.26 |
Valuation Ratios
The PE ratio is 18.71 and the forward PE ratio is 9.16. Pfizer's PEG ratio is 0.07.
| PE Ratio | 18.71 |
| Forward PE | 9.16 |
| PS Ratio | 2.36 |
| Forward PS | 2.6 |
| PB Ratio | 1.7 |
| P/FCF Ratio | 15.28 |
| PEG Ratio | 0.07 |
Enterprise Valuation
Pfizer Inc. has an Enterprise Value (EV) of 234.65B.
| EV / Earnings | 29.22 |
| EV / Sales | 3.69 |
| EV / EBITDA | 12.94 |
| EV / EBIT | 15.71 |
| EV / FCF | 23.86 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.17 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.72 |
| Total Debt / Capitalization | 41.92 |
| Cash Flow / Debt | 0.2 |
| Interest Coverage | 4.83 |
Financial Efficiency
Return on equity (ROE) is 0.09% and return on capital (ROIC) is 9.85%.
| Return on Equity (ROE) | 0.09% |
| Return on Assets (ROA) | 0.04% |
| Return on Capital (ROIC) | 9.85% |
| Revenue Per Employee | $785,518.52 |
| Profits Per Employee | $99,148.15 |
| Employee Count | 81,000 |
| Asset Turnover | 0.3 |
| Inventory Turnover | 1.51 |
Taxes
| Income Tax | -28M |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -3.58% in the last 52 weeks. The beta is 0.54, so Pfizer's price volatility has been higher than the market average.
| Beta | 0.54 |
| 52-Week Price Change | -3.58% |
| 50-Day Moving Average | 26.22 |
| 200-Day Moving Average | 27.64 |
| Relative Strength Index (RSI) | 51.01 |
| Average Volume (20 Days) | 38.62M |
Income Statement
In the last 12 months, Pfizer had revenue of 63.63B and earned 8.03B in profits. Earnings per share was 1.42.
| Revenue | 63.63B |
| Gross Profit | 47.21B |
| Operating Income | 14.94B |
| Net Income | 8.03B |
| EBITDA | 18.13B |
| EBIT | 14.94B |
| Earnings Per Share (EPS) | 1.42 |
Balance Sheet
The company has 1.04B in cash and 63.65B in debt, giving a net cash position of -62.61B.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 63.65B |
| Net Cash | -62.61B |
| Retained Earnings | 116.72B |
| Total Assets | 213.4B |
| Working Capital | 7.36B |
Cash Flow
In the last 12 months, operating cash flow was 12.74B and capital expenditures -2.91B, giving a free cash flow of 9.84B.
| Operating Cash Flow | 12.74B |
| Capital Expenditures | -2.91B |
| Free Cash Flow | 9.84B |
| FCF Per Share | 1.74 |
Margins
Gross margin is 74.19%, with operating and profit margins of 23.48% and 12.62%.
| Gross Margin | 74.19% |
| Operating Margin | 23.48% |
| Pretax Margin | 12.61% |
| Profit Margin | 12.62% |
| EBITDA Margin | 28.49% |
| EBIT Margin | 23.48% |
| FCF Margin | 15.46% |
Dividends & Yields
PFE pays an annual dividend of $2.11, which amounts to a dividend yield of 6.48%.
| Dividend Per Share | $2.11 |
| Dividend Yield | 6.48% |
| Dividend Growth (YoY) | 2.38% |
| Payout Ratio | 149.65% |
| Earnings Yield | 5.38% |
| FCF Yield | 6.58% |
Analyst Forecast
The average price target for PFE is $31, which is 17.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $31 |
| Price Target Difference | 17.5% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Nov 17, 2020. It was a forward split with a ratio of 527:500.
| Last Split Date | Nov 17, 2020 |
| Split Type | forward |
| Split Ratio | 527:500 |
Scores
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 8 |